Africa village huts
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Asara Resources (ASX:AS1) has announced its sale of its Burkina Faso assets for US$2.2M in cash.

The funds will go towards the advancement of Asara’s Kada gold project in Guinea – a jurisdiction somewhat more stable. The company will also pay off debts with the funds.

Expressed in Australian dollars, the company is to receive $3.25M in cash. Asara already has US$0.55M in its coffers as an upfront payment.

A second US$0.55M will come to the company upon execution of a Share Purchase Agreement (SPA) with private explorer BIC West Africa.

The two projects BIC has picked up are Asara’s Kouri and Babonga projects.

But both projects are part of a troubled history for Asara, as far as trying to get rid of them goes.

Back in 2022, when Asara was called Golden Rim, it announced to the market that it was going to sell both assets for US$15M. Two years later, it’s still trying to pawn them off – and at a far lower cost.

All in all, Burkina Faso is a notoriously difficult place for foreign companies to do business.

“The BIC group have been making great progress on their other assets within Burkina Faso and we are confident that they are the right group to take exploration at Kouri and Babonga further for the benefit the local community and government of Burkina Faso,” Asara MD Tim Strong said.

“We wish them well with their exploration efforts.”

AS1 last traded at 0.9cps.

AS1 by the numbers
More From The Market Online
Image of Mt Isa creek

Extensive sampling and mapping program pays off for Hammer in QLD’s Mt Isa gold-copper project

Hammer Metals Ltd has identified a list of priority targets across its Mt Isa tenements through…
The skyline of Saudi Capital Riyadh

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

You may have noticed in the last few years the name of a particular Kingdom popping…
Brain chemistry concept AI gen

Antidepressant Xanamem shows further improvements four weeks after 6-week treatment: 10mg daily dose

Actinogen (ASX:ACW) has reported success in using its novel antidepressant Xanamem to mitigate the symptoms of…
Market Update Graphic

ASX Market Update: Discretionary & Financials lead Index higher | August 26, 2024

The ASX200 has started the week on a positive note, up 0.69% at 8,080 points. Real…